PMID- 32980534 OWN - NLM STAT- MEDLINE DCOM- 20210115 LR - 20210115 IS - 1873-2585 (Electronic) IS - 1047-2797 (Linking) VI - 52 DP - 2020 Dec TI - The impact of metformin on survival in patients with melanoma-national cohort study. PG - 23-25 LID - S1047-2797(20)30380-X [pii] LID - 10.1016/j.annepidem.2020.09.010 [doi] AB - PURPOSE: The primary study outcome was melanoma-specific mortality in patients with type 2 diabetes mellitus (T2DM) using metformin. METHODS: Data regarding patients were provided by the Lithuanian Cancer Registry and were linked with National Health Insurance Fund in accordance with unique personal identification numbers during the period of thirteen years. RESULTS: About 2817 patients met eligibility criteria and were included in the retrospective cohort study. About 163 patients had pre-existing T2DM and 103 of them were treated with metformin. In the multivariable analysis, there was significant risk difference in melanoma-specific survival between diabetic, metformin-using patients, and nondiabetic patients (P=0.02) in favor of metformin users. CONCLUSION: Melanoma patients with T2DM treated with metformin had lower risk of melanoma-specific mortality; however, prospective controlled studies are mandatory to confirm this finding. CI - Copyright (c) 2020 Elsevier Inc. All rights reserved. FAU - Urbonas, Vincas AU - Urbonas V AD - Clinic of Internal Diseases, Family Medicine and Oncology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania; Laboratory of Clinical Oncology, National Cancer Institute, Vilnius, Lithuania. Electronic address: vincas.urbonas@nvi.lt. FAU - Rutenberge, Julija AU - Rutenberge J AD - Faculty of Medicine, Vilnius University, Vilnius, Lithuania. FAU - Patasius, Ausvydas AU - Patasius A AD - Laboratory of Cancer Epidemiology, National Cancer Institute, Vilnius, Lithuania; Department of Public Health, Institute of Health Sciences, Faculty of Medicine, Vilnius, Lithuania. FAU - Dulskas, Audrius AU - Dulskas A AD - Department of Abdominal and General Surgery and Oncology, National Cancer Institute, Vilnius, Lithuania; Faculty of Health Care, University of Applied Sciences, Vilnius, Lithuania; Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania. FAU - Burokiene, Neringa AU - Burokiene N AD - Clinic of Internal Diseases, Family Medicine and Oncology, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania. FAU - Smailyte, Giedre AU - Smailyte G AD - Laboratory of Cancer Epidemiology, National Cancer Institute, Vilnius, Lithuania; Department of Public Health, Institute of Health Sciences, Faculty of Medicine, Vilnius, Lithuania. LA - eng PT - Journal Article DEP - 20200924 PL - United States TA - Ann Epidemiol JT - Annals of epidemiology JID - 9100013 RN - 0 (Hypoglycemic Agents) RN - 9100L32L2N (Metformin) SB - IM MH - Adult MH - Aged MH - Aged, 80 and over MH - Cohort Studies MH - Diabetes Mellitus, Type 2/*complications/*drug therapy/epidemiology MH - Female MH - Humans MH - Hypoglycemic Agents/*therapeutic use MH - Kaplan-Meier Estimate MH - Lithuania/epidemiology MH - Male MH - Melanoma/complications/*mortality MH - Metformin/*therapeutic use MH - Middle Aged MH - Population Surveillance MH - Retrospective Studies MH - Survival Rate OTO - NOTNLM OT - Diabetes OT - Melanoma OT - Metformin OT - Survival EDAT- 2020/09/28 06:00 MHDA- 2021/01/16 06:00 CRDT- 2020/09/27 20:24 PHST- 2020/04/08 00:00 [received] PHST- 2020/09/07 00:00 [revised] PHST- 2020/09/16 00:00 [accepted] PHST- 2020/09/28 06:00 [pubmed] PHST- 2021/01/16 06:00 [medline] PHST- 2020/09/27 20:24 [entrez] AID - S1047-2797(20)30380-X [pii] AID - 10.1016/j.annepidem.2020.09.010 [doi] PST - ppublish SO - Ann Epidemiol. 2020 Dec;52:23-25. doi: 10.1016/j.annepidem.2020.09.010. Epub 2020 Sep 24.